On August 31, 2023 Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, reported that the Company will participate in three upcoming investor conferences taking place in September (Press release, Kezar Life Sciences, AUG 31, 2023, View Source [SID1234634819]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: 2023 Wells Fargo Healthcare Conference
Location: Boston, MA
Date/Time: Thursday, September 7, 2023, at 12:45 pm ET
Presenter: Noreen R. Henig, M.D., Chief Medical Officer
Format: Fireside Chat
Event: Morgan Stanley 21st Annual Global Healthcare Conference
Location: New York, NY
Date/Time: Tuesday, September 12, 2023, at 10:50 am ET
Presenter: John Fowler, Co-Founder and Chief Executive Officer
Format: Fireside Chat
Event: H.C. Wainwright 25th Annual Global Investment Conference
Location: New York, NY
Date/Time: Wednesday, September 13, 2023, at 12:30 pm ET
Presenter: John Fowler, Co-Founder and Chief Executive Officer
Format: Podium Presentation

Webcasts from the presentations will be available on the "Events & Presentations" section of the Company’s website at www.kezarlifesciences.com. Following the events, archived webcasts will be available on the Kezar website for 90 days.